Spots Global Cancer Trial Database for ustekinumab
Every month we try and update this database with for ustekinumab cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
A Study of JNJ-64304500 as Add-on Therapy in Participants With Active Crohn's Disease | NCT04655807 | Crohn Disease | JNJ-64304500 Placebo Adalimumab Ustekinumab | 18 Years - 65 Years | Janssen Research & Development, LLC | |
Predictive Factors of Clinical Response to Ustekinumab in Active Crohn's Disease | NCT03351647 | Crohn Disease | Evaluation of b... | 18 Years - 18 Years | Hospices Civils de Lyon | |
Ustekinumab for the Prevention of Acute Graft-versus-Host Disease After Unrelated Donor Hematopoietic Cell Transplant | NCT04572815 | Hematologic and... Hematopoietic a... | Placebo Adminis... Quality-of-Life... Questionnaire A... Ustekinumab | 18 Years - 70 Years | Fred Hutchinson Cancer Center |